Forms Processing
PRODUCTS
-
Guide operators through dynamic workflows from equipment startup to maintenance.
-
PHCbi brand’s 7.6 cu.ft (218 L) pharmaceutical refrigerator offers a compact and efficient solution for clinical, laboratory, and vaccine storage applications. Designed with a slim profile and flexible interior layout, it supports a wide temperature setpoint range from 2°C to 14°C, ideal for sensitive biologics and pharmaceuticals.The unit features adjustable shelving to accommodate various container sizes and workflow needs, while the triple-pane glass door with optional blackout panel enhances visibility and security. ENERGY STAR® Certified.
-
Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.
-
Natoli Scientific’s preclinical stability studies represent a critical facet of our pharmaceutical testing services, providing essential data on the shelf life and storage conditions of drug candidates. These studies are expertly designed to evaluate physical, chemical, and microbiological stability, ensuring that formulations retain their safety, efficacy, and quality over time. Our state-of-the-art facilities simulate various environmental conditions to scrutinize the integrity of products under stress-testing scenarios. The results gleaned from our stability studies guide the development of robust drug formulations and packaging, aid in regulatory submissions, and lay the groundwork for successful commercialization.
-
Safety pharmacology is the cornerstone of responsible drug development. It involves the evaluation of a drug candidate's potential impact on vital organ systems such as the cardiovascular, respiratory, and central nervous systems. By identifying any potential safety concerns early in the development process, safety pharmacology studies play a crucial role in minimizing risks to patients and ensuring the overall safety and efficacy of the final product.
WHITE PAPERS AND CASE STUDIES
-
Peace River Manasota Regional Water Supply Authority Uses Powdered Activated Carbon To Ensure High Quality Drinking Water
Founded in 1982, Peace River Manasota Regional Water Supply Authority supplies drinking water to a region of approximately one million people. Its surface water treatment plant draws water from the Peace River to a reservoir and treats it to drinking water standards at the rate of about 31 million gallons a day.
-
How Advanced Biological Technologies Overcome Complex Wastewater Treatment Challenges In The Oil And Gas Sector
This white paper explores how advanced biological technologies — including MBBR, IFAS, SBR, and MBR systems — are transforming wastewater management in this sector.
-
MilliporeSigma's 97-Day Implementation Success Story
Read how MilliporeSigma transformed validation processes with a digital validation system to achieve compliance in just 97 days, as well as learn key takeaways from their swift transition.
-
A Risk-Based Approach To Plasmid DNA And mRNA Process Development
Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.
-
How A Pharma Company Improved Yield By 1.5% In Just Three Months
A pharma company faced a 4% yield drop and variability at a manufacturing facility. Explore how they leveraged an AI-based platform to unify data, pinpoint inefficiencies, and enhance consistency in yields.
-
Improving The eCOA Experience
Discover how template-driven builds and reuse can slash eCOA timelines by 50% while solving the licensing and translation hurdles that delay First Patient In.
-
Everest Group Life Sciences eCOA Peak Matrix Assessment 2025
Discover how digital platforms are revolutionizing clinical trials by improving data quality and patient engagement in this comprehensive market assessment.
-
Flexible Fill/Finish Solutions To Bridge The Clinical-To-Commercial Gap
As biopharma complexity grows, flexible CDMOs are essential for navigating evolving fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.
-
Transitioning Your Product From Phase 1 To Phase 2 Clinical Studies
Strategic partnerships can streamline your transition from Phase 1 to Phase 2 clinical studies, ensuring optimized dosage forms, seamless scale-up, and alignment with patient and study requirements.
-
Hunting An Unexpected mAb Variant With LC‑MS
A tailored LC–MS approach enables sensitive detection and tracking of monoclonal antibody variants, supporting deeper product characterization and better control of quality‑impacting changes.
-
Implementation of the New European Health Technology Assessment Regulation (HTAR)
The European Health Technology Assessment Regulation (HTAR) requires joint clinical assessments for certain therapies starting 2025, impacting market access preparation for companies in the EU.
-
Catalent's Journey Of Continuous Improvement For CSV Excellence
Learn how organizations must continuously reassess validation processes and digital tools to ensure compliance, enhance efficiency, and support global scalability amidst evolving regulatory expectations.
NEWS
-
Inspect Point Announces Strategic Integration With Simpro To Enhance Fire Protection & Field Service Management Solution3/21/2025
Inspect Point, a leading fire protection software provider, is thrilled to announce its strategic partnership and integration with Simpro, a global leader in field service management solutions.
-
Insurance Pros Of Central Arkansas Selects EZLynx To Modernize Operations And Enhance Client Service3/11/2025
EZLynx, an Applied company, today announced that Insurance Pros of Central Arkansas has selected the EZLynx management system to enhance its operations and give agents back valuable time to focus on client interactions.
-
Descartes Showcases AI Innovations To Help Improve Supply Chain And Logistics Operations2/9/2026
Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, is showcasing its latest technology innovations focused on artificial intelligence (AI) and advanced automation at Manifest 2026 from February 9–11 in Las Vegas.
-
Launch Of Fleetwaro.ai, The New Cloud-Based Fleet Platform For Intelligent, AI-Powered Fleet Management12/5/2025
Fleetwaro.ai is a cloud-based software for fleet management with the power of AI. It is designed for fleet managers who want to manage their vehicle fleets, regardless of size or industry, in a structured and cost-efficient way.
-
Bioxytran Develops A Groundbreaking Treatment To Combat Bird Flu In Egg Laying Chickens Potentially Saving Billions3/12/2025
BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, unveiled a potential game-changer in the fight against Highly Pathogenic Avian Influenza (HPAI), commonly known as Bird Flu.